Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR03P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,916
Award facts
- Contract value 100% obligated
- $44,915.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 15, 2025, for RINVOQ ER 15 mg tablets (30-count units). The contract is valued at $44,915.79 and represents a firm fixed-price delivery order with a completion date of December 16, 2025. This award is a competitive, non-set-aside contract and operates as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania.
RINVOQ (upadacitinib) is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions. This delivery order reflects the ongoing pharmaceutical supply chain support that AmerisourceBergen provides to the Department of Defense through the DLA, which sources medications and medical supplies for military healthcare systems, the Defense Health Agency, and other federal health programs. The competitively awarded order demonstrates AmerisourceBergen's established capability to fulfill federal medical procurement requirements within the broader context of the DLA's pharmaceutical vendor network and strategic multi-award contracting initiatives.
Quick answers
Who was awarded contract SPE2DR26FR03P?
SPE2DR26FR03P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FR03P worth?
The government has obligated $44,916 on SPE2DR26FR03P.
Is contract SPE2DR26FR03P an order under another contract?
Yes. SPE2DR26FR03P is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR03P competed?
The extent of competition for SPE2DR26FR03P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award